We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 05 JUNE 2013
Claim Construction Turns On Patentee Disclaimer
McDermott Will & Emery
Declining to hold that one epitope can count as two, the U.S. Court of Appeals for the Federal Circuit upheld a lower court’s narrow construction of the term "anti-CD20 antibody".
United StatesIntellectual Property








